Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Finished Goods (2021 - 2024)

Historic Finished Goods for Universe Pharmaceuticals (UPC) over the last 5 years, with Q3 2025 value amounting to $1.6 billion.

  • Universe Pharmaceuticals' Finished Goods rose 4090.69% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 4090.69%. This contributed to the annual value of $1.6 billion for FY2025, which is 4090.69% up from last year.
  • Latest data reveals that Universe Pharmaceuticals reported Finished Goods of $1.6 billion as of Q3 2025, which was up 4090.69% from $1.1 billion recorded in Q3 2024.
  • In the past 5 years, Universe Pharmaceuticals' Finished Goods registered a high of $1.6 billion during Q3 2025, and its lowest value of $1.3 million during Q3 2022.
  • Over the past 5 years, Universe Pharmaceuticals' median Finished Goods value was $2.8 million (recorded in 2023), while the average stood at $551.2 million.
  • Per our database at Business Quant, Universe Pharmaceuticals' Finished Goods plummeted by 3214.08% in 2022 and then soared by 4099727.87% in 2024.
  • Universe Pharmaceuticals' Finished Goods (Quarter) stood at $2.0 million in 2021, then tumbled by 32.14% to $1.3 million in 2022, then soared by 107.64% to $2.8 million in 2023, then skyrocketed by 40997.28% to $1.1 billion in 2024, then surged by 40.91% to $1.6 billion in 2025.
  • Its Finished Goods was $1.6 billion in Q3 2025, compared to $1.1 billion in Q3 2024 and $2.8 million in Q3 2023.